Equillium (EQ) Cash & Current Investments (2017 - 2026)
Equillium (EQ) reported Cash & Current Investments of $60.4 million for Q1 2026, up 316.48% year-over-year from $14.5 million in Q1 2025, and up 103.11% quarter-over-quarter from $29.7 million in Q4 2025.
Equillium (EQ) Cash & Current Investments (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Cash & Current Investments data on file, last reported at $60.4 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $60.4 million, up 316.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.4 million (up 316.48% YoY), and the FY2025 annual result was $29.7 million, up 31.71% from the prior year.
- Cash & Current Investments grew to $60.4 million in Q1 2026 per EQ's latest filing, from $29.7 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $71.0 million in Q4 2022 and troughed at $11.5 million in Q2 2025.
- A 5-year average of $41.3 million and a median of $40.9 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2025 and 2026: Cash & Current Investments slumped 65.48% in 2025, then soared 316.48% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $71.0 million in 2022, then tumbled by 42.46% to $40.9 million in 2023, then slumped by 44.76% to $22.6 million in 2024, then jumped by 31.71% to $29.7 million in 2025, then jumped by 103.11% to $60.4 million in 2026.
- Business Quant data shows EQ's Cash & Current Investments at $60.4 million in Q1 2026, $29.7 million in Q4 2025, and $33.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 60.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.39 Mn |
| Dec 31, 2025 | 29.73 Mn |
| Sep 30, 2025 | 33.12 Mn |
| Jun 30, 2025 | 11.50 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Dec 31, 2024 | 22.58 Mn |
| Sep 30, 2024 | 25.88 Mn |
| Jun 30, 2024 | 33.30 Mn |
| Mar 31, 2024 | 32.29 Mn |
| Dec 31, 2023 | 40.87 Mn |
| Sep 30, 2023 | 46.31 Mn |
| Jun 30, 2023 | 48.38 Mn |
| Mar 31, 2023 | 61.99 Mn |
| Dec 31, 2022 | 71.02 Mn |
| Sep 30, 2022 | 44.52 Mn |
| Jun 30, 2022 | 57.56 Mn |
| Mar 31, 2022 | 68.82 Mn |
| Dec 31, 2021 | 80.71 Mn |
| Sep 30, 2021 | 90.69 Mn |
| Jun 30, 2021 | 97.64 Mn |